In HNSCC models that preserve tumor-draining lymphatics, cDC1 accumulation and type-I-interferon signaling are necessary for response to checkpoint blockade; disruption of lymphatic egress abrogates these features and diminishes efficacy (48, 49). The gene discussed is MPPE1; the disease is head and neck squamous cell carcinoma.